ArticleBreast cancer research and treatment2018

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.

Nouf Al-Subhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.